MedTrace Logo

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

NCT02938611 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3375

Last updated 2025-03-10

No results posted yet for this study

Summary

The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.

Conditions

  • Renal Insufficiency, Chronic

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Olivier Moranne, MD, PhD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02938611 on ClinicalTrials.gov